Literature DB >> 1838260

A meta-analysis of reported correlations between prognostic factors in breast cancer: does axillary lymph node metastasis represent biology or chronology?

I Mittra1, K D MacRae.   

Abstract

A statistical overview of published results on correlations between various prognostic factors in breast cancer was undertaken. A distinction was made between clinical (or anatomical) prognostic factors--namely, axillary lymph node status and tumour size--and eight different biological prognostic factors. The latter included: tumour grade, oestrogen and progesterone receptor status, thymidine labelling index, DNA ploidy, S-phase fraction, epidermal growth factor receptor expression and c-erbB-2 gene amplification (or overexpression). 139 articles were eligible for review which reported a total of 432 individual correlations. A simple form of meta-analysis was employed: the counting method, in which the number of studies achieving a statistically significant correlation or not were counted. For each possible correlation examined, the proportion of studies showing a statistically significant correlation was calculated and an exact binomial 99% confidence interval determined for that proportion. If the 99% confidence interval included 5% (the proportion of correlations that would be expected to be statistically significant if the null hypothesis was true), it was taken as failing to exclude the null hypothesis of a zero correlation, while if it excluded 5% it was taken as rejecting the null hypothesis of a zero correlation. A broad agreement was found among published reports on the existence of a statistically significant correlation between the various biological prognostic factors in breast cancer. Of the 20 correlations examined, 18 had a 99% confidence interval excluding 5%, thus rejecting the null hypothesis of a zero correlation. On the other hand, a completely different result was obtained when reports on possible correlations between lymph node status and tumour size on the one hand and the eight biological prognostic factors on the other were analysed. Of the 16 correlations examined, 13 had a 99% confidence interval including 5%, failing to reject the null hypothesis of a zero correlation. These observations suggest the hypothesis that the prognostic influence of node status and tumour size cannot be explained by an analysis of the biology of breast cancer; and is compatible with the contention that axillary node status is merely a reflection of the relative chronological age of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1838260     DOI: 10.1016/0277-5379(91)90418-d

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  9 in total

1.  Prognostic and Predictive Factors for Breast Cancer.

Authors: 
Journal:  Breast Cancer       Date:  1995-10-31       Impact factor: 4.239

2.  Modeling effective tumor burden of primary lesion and metastatic lymph node in breast cancer patients from the SEER database.

Authors:  Taobo Hu; Jinbo Wu; Mengping Long; Xiaojie Zhou; Shu Wang
Journal:  Gland Surg       Date:  2022-01

3.  Relation between socioeconomic deprivation and pathological prognostic factors in women with breast cancer.

Authors:  A G Carnon; A Ssemwogerere; D W Lamont; D J Hole; E A Mallon; W D George; G R Gillis
Journal:  BMJ       Date:  1994-10-22

4.  Downregulation of hsa_circ_0006220 and its correlation with clinicopathological factors in human breast cancer.

Authors:  Chong Liu; Mingshi Chen; Yue Shi
Journal:  Gland Surg       Date:  2021-02

5.  Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene.

Authors:  D S Liscia; R Morizio; T Venesio; C Palenzona; M Donadio; R Callahan
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

6.  Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size.

Authors:  L Bucchi; A Barchielli; A Ravaioli; M Federico; V De Lisi; S Ferretti; E Paci; M Vettorazzi; S Patriarca; A Frigerio; E Buiatti
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

7.  Impact of tumor chronology and tumor biology on lymph node metastasis in breast cancer.

Authors:  Ann Smeets; Andries Ryckx; Ann Belmans; Hans Wildiers; Patrick Neven; Giuseppe Floris; Patrick Schöffski; Marie-Rose Christiaens
Journal:  Springerplus       Date:  2013-09-23

8.  Determination of c-erbB-2 protein in primary breast cancer tissue extract using an enzyme immunoassay.

Authors:  T Watanabe; T Fukutomi; H Tsuda; I Adachi; T Nanasawa; H Yamamoto; K Abe
Journal:  Jpn J Cancer Res       Date:  1993-12

9.  Differentiating the lymph node metastasis of breast cancer through dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Xu Dong; Yu Chunrong; Hou Hongjun; Zhang Xuexi
Journal:  BJR Open       Date:  2019-05-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.